@ambaln.bsky.social

In extremely preterm infants, intratracheal budesonide mixed with surfactant did not reduce bronchopulmonary dysplasia or death by 36 weeks' postmenstrual age. ja.ma/4738oYb

Infographic from JAMA comparing budesonide and surfactant vs surfactant alone for reducing bronchopulmonary dysplasia/death in preterm infants. It includes population data (320 male, 319 female), intervention details, and findings showing no significant difference between groups.

📢 Join @ats-peds.bsky.social on Tue, July. 22 at 1PM ET! Dr. Cindy McEvoy (OHSU) presents: "Extended CPAP in Preterm Infants Increases Lung Growth at 6 Months: A RCT." 🩺Featuring a panel of experts + moderated discussion on clinical impact & future care. 🔗Register Now!

American Thoracic Society | Extended Continuous Positive Airway…

The American Thoracic Society is the world's leading medical society dedicated to accelerating the advancement of global respiratory health through…

site.thoracic.org